Ann: ADDRESS: FPH: FPH Announces New Products at Investor Day

• Release Date: 13/10/15 09:05
• Summary: ADDRESS: FPH: FPH Announces New Products at Investor Day
• Price Sensitive: No
• Download Document  4.17KB

					FPH
13/10/2015 09:05
ADDRESS
NOT PRICE SENSITIVE
REL: 0905 HRS Fisher & Paykel Healthcare Corporation Limited

ADDRESS: FPH: FPH Announces New Products at Investor Day

FISHER & PAYKEL HEALTHCARE ANNOUNCES NEW NASAL MASK AND SURGICAL
HUMIDIFICATION SYSTEM AT INVESTOR DAY

Auckland, New Zealand, 13 October 2015 - Fisher & Paykel Healthcare
Corporation Limited (NZSX:FPH, ASX:FPH) will announce today at its investor
day in Sydney the introduction of two innovative new products, the F&P EsonTM
2 nasal mask for the treatment of obstructive sleep apnea (OSA) and the F&P
HumiGardTM SH870 System for the delivery of warm, humidified CO2 during open
and laparoscopic surgery.

F&P EsonTM 2 Nasal Mask
The F&P Eson 2 is the first of the next generation of Fisher & Paykel
Healthcare's comfortable and easy-to-use masks and builds on the success of
the F&P Eson nasal mask with more than 20 design improvements.

"Our development team has focused on ease of use, to provide sleep
professionals and patients confidence at every step from titration through to
adherence" commented Lewis Gradon, Fisher & Paykel Healthcare's Senior Vice
President of Products and Technology and CEO Designate. "The F&P Eson has
been our best performing nasal mask and has proven extremely popular with
both healthcare providers and patients. We believe with the large number of
design improvements the F&P Eson 2 will be even more popular" said Mr Gradon.

F&P Eson 2 retains the same patented RollFit(TM) Seal technology as F&P Eson.
RollFit automatically adjusts to effectively fit a wide variety of faces and
aims to maintain a seal while minimising the force applied to the bridge of
the nose. The F&P Eson 2 includes intuitive headgear which has been
completely redesigned for improved usability and fitting. VisiBlue(TM)
highlights have been incorporated into key mask components to assist patients
with mask orientation, use, and assembly. VisiBlue also assists providers to
simplify instruction on equipment use and care.

"We put the patient and their needs at the centre of our mask design and,
like all of our masks, the F&P Eson 2 is designed to seal comfortably,
simplify use and improve treatment acceptability. Our innovative technologies
have significantly advanced mask simplicity and performance, increasing the
chance of long-term therapy success and, ultimately, improving patient care
and outcomes" said Mr Gradon.

The F&P Eson 2 mask will initially be available in New Zealand and Australia
from November, followed by Canada and Europe and then the United States on
receipt of US FDA clearance.

F&P HumiGardTM SH870 Surgical Humidification System
Design of the F&P HumiGard(TM) SH870 Surgical Humidification System has
focused on simplicity and usability for time-poor surgical staff. Auto detect
software enables automatic detection of flow variations required for
insufflation during open and laparoscopic surgery, while a preassembled
tubing set significantly reduces setup time. Feedback from surgical staff has
been critical in refining the delivery of this next generation technology
enabling therapy adoption to be as seamless as possible.

"In recent years the focus of surgical humidification has been on its use
during laparoscopic surgery, however mounting clinical evidence has
demonstrated significant patient benefits such as improved perioperative
hypothermia when utilised during open surgery. We believe that this new
HumiGard system will facilitate accelerated growth in the uptake of surgical
humidification by hospitals in a number of our key markets" concluded Mr
Gradon.

The SH870 is being introduced into New Zealand, Australia, and the UK in
November followed by multiple European markets in January.

The company also attaches a copy of its presentation to investors and
analysts at its investor day in Sydney.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer
of products and systems for use in respiratory care, acute care, surgery and
the treatment of obstructive sleep apnea.  The company's products are sold in
over 120 countries worldwide. For more information about the company, visit
our website www.fphcare.com.
End CA:00271629 For:FPH    Type:ADDRESS    Time:2015-10-13 09:05:25